JAK Inhibitors Remain a Viable Option for Older Adults With IBD

(MedPage Today) -- SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel disease (IBD) in older adults, according to two poster presentations.
In the first one, Nicole Garcia...